Search

Your search keyword '"Wu Xikun"' showing total 48 results

Search Constraints

Start Over You searched for: Author "Wu Xikun" Remove constraint Author: "Wu Xikun"
48 results on '"Wu Xikun"'

Search Results

2. Population Pharmacokinetics and Dosing Optimization of Norvancomycin for Chinese Patients with Community-Acquired Pneumonia.

7. Workflow-based systematic design of high throughput genome annotation

8. Abstract LB289: Longitudinal ctDNA levels and clinical outcomes of first-line (1L) tislelizumab (TIS) + chemotherapy (chemo) treatment for advanced non-small cell lung cancer (NSCLC) in the RATIONALE-304 and 307 studies

9. Fast Initial Rotor Position Estimation for IPMSM With Unipolar Sequence-Pulse Injection

10. Determination of Free Valproic Acid Concentration in 569 Clinical Samples by LC-MS/MS After Hollow Fiber Centrifugal Ultrafiltration Treatment

11. Ciprofol: A Novel Alternative to Propofol in Clinical Intravenous Anesthesia?

18. Abstract LB511: The combination of hyper-amplification and tumor mutational burden as a pan-cancer biomarker in patients treated with tislelizumab

19. A combined experimental-numerical approach for the development of bio-based composite by and for additive manufacturing

20. Therapeutic drug monitoring of free vancomycin concentration in practice: A new analytical technique based on the HFCF–UF sample separation method.

21. Safety, tolerability, and preliminary antitumor activity of sitravatinib plus tislelizumab (TIS) in patients (pts) with unresectable locally advanced or metastatic hepatocellular carcinoma (HCC).

24. Offline Inductance Identification of IPMSM With Sequence-Pulse Injection

25. 360 Tumor-immune signatures associated with response or resistance to tislelizumab in patients with previously treated advanced hepatocellular carcinoma (HCC)

26. 362 Association of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with clinical outcomes to tislelizumab monotherapy in patients with previously treated advanced hepatocellular carcinoma

27. CYP2C9*3/*3 Gene Expression Affects the Total and Free Concentrations of Valproic Acid in Pediatric Patients with Epilepsy

29. 77 Association between programmed death-ligand 1 (PD-L1) expression and gene signatures of response or resistance to tislelizumab monotherapy in hepatocellular carcinoma (HCC)

30. 76 Potential mechanisms of resistance identified through analysis of multiple biomarkers in immune hot non-responders with non-small cell lung cancer (NSCLC) treated with tislelizumab

31. Immune- and tumor-intrinsic gene expression profiles of response or resistance to tislelizumab as monotherapy or in combination with chemotherapy in non-small cell lung cancer (NSCLC).

33. Magnetic Equivalent Circuit Framework for an Axial Flux Permanent Magnet Synchronous Machine

34. Off-line Stator Resistance Identification for PMSM with Pulse Signal Injection avoiding the Dead-time Effect

41. Work ow-based systematic design of high throughput genome annotation

42. Genomic analysis of the causative agents of coccidiosis in domestic chickens

43. Genomic analysis of the causative agents of coccidiosis in domestic chickens

45. Sequencing and analysis of chromosome 1 of Eimeria tenella reveals a unique segmental organization.

46. Sequencing and analysis of chromosome 1 of Eimeria tenella reveals a unique segmental organization

47. Clinical Efficacy and Safety of Vancomycin Based on Unbound Vancomycin Concentration Monitoring.

48. [Pharmacokinetic profiles of antifungal drugs during extracorporeal membrane oxygenation life support].

Catalog

Books, media, physical & digital resources